Sources | Names Used |
---|---|
CTRPv2 | selumetinib:piperlongumine (8:1 mol/mol) |
PharmacoGx | selumetinib:piperlongumine (8:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | RNASE2 | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-05 |
mRNA | CLDN4 | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-05 |
mRNA | MRGPRG | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-05 |
mRNA | TSNARE1 | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-05 |
mRNA | CLIC4 | CTRPv2 | pan-cancer | AAC | -0.17 | 2e-05 |
mRNA | MCEMP1 | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-05 |
mRNA | TST | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-05 |
mRNA | CACNA1S | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-05 |
mRNA | LAD1 | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-05 |
mRNA | PLPPR3 | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-05 |